Xilio Therapeutics (XLO) Leases (2024 - 2025)
Xilio Therapeutics' Leases history spans 2 years, with the latest figure at $4.1 million for Q3 2025.
- For Q3 2025, Leases fell 12.77% year-over-year to $4.1 million; the TTM value through Sep 2025 reached $4.1 million, down 12.77%, while the annual FY2024 figure was $4.6 million, N/A changed from the prior year.
- Leases for Q3 2025 was $4.1 million at Xilio Therapeutics, down from $4.3 million in the prior quarter.
- Across five years, Leases topped out at $5.0 million in Q1 2024 and bottomed at $4.1 million in Q3 2025.